Latin America Drug Discovery Informatics Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$307.6

Forecast, 2030 (US$M)

$660.9

CAGR, 2024 - 2030

11.5%

Report Coverage

Latin America

Latin America drug discovery informatics market, 2018-2030 (US$M)

Related Markets

Global Drug Discovery Informatics Industry Outlook

North America Drug Discovery Informatics Market Outlook

Europe Drug Discovery Informatics Market Outlook

Asia Pacific Drug Discovery Informatics Market Outlook

MEA Drug Discovery Informatics Market Outlook

Latin America drug discovery informatics market highlights

The Latin America drug discovery informatics market generated a revenue of USD 307.6 million in 2023.
The market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
In terms of segment, discovery informatics was the largest revenue generating work-flow in 2023.
Discovery Informatics is the most lucrative work-flow segment registering the fastest growth during the forecast period.

Latin America data book summary

Market revenue in 2023	USD 307.6 million
Market revenue in 2030	USD 660.9 million
Growth rate	11.5% (CAGR from 2023 to 2030)
Largest segment	Discovery informatics
Fastest growing segment	Discovery Informatics
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Discovery Informatics
Key market players worldwide	Certara Inc Ordinary Shares, Boehringer Ingelheim, Infosys Ltd ADR, Charles River Laboratories International Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Oracle Corp, Accenture PLC Class A, Agilent Technologies Inc, Illumina Inc, Eurofins Scientific SE, Jubilant Biosys, Selvita, ChemAxon, Albany Molecular Research

Other key industry trends

In terms of revenue, Latin America region accounted for 9.4% of the global drug discovery informatics market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 1,636.5 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Drug Discovery Informatics Market Scope

Drug discovery informatics market segmentation & scope

Work-flow

Discovery Informatics

Identification & Validation Informatics Assay Development Informatics

Lead Generation Informatics

Development Informatics

Lead Optimization

FHD Preparation

Phase IA Informatics

Phase IB/2 Informatics

Mode

Outsourced Informatics

In-house Informatics

Services

Sequence Analysis Platforms

Molecular Modelling

Docking

Clinical trial data management

Others

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Germany

Japan

China

Brazil

South Africa

Drug Discovery Informatics Market Companies

Name	Profile	# Employees	HQ	Website

Latin America drug discovery informatics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery informatics market will help companies and investors design strategic landscapes.

Discovery informatics was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America drug discovery informatics market based on discovery informatics covering the revenue growth of each sub-segment from 2018 to 2030.

Rise in the number of sequencers installed in this region are expected to drive the demand for data analysis platforms and algorithmic solutions in this region. However, absence of market entities is attributive to support in revenue generation by outsourcing the informatics services from dominant regions such as U.S. and Canada.

Reasons to subscribe to Latin America drug discovery informatics market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Latin America drug discovery informatics market databook

Our clientele includes a mix of drug discovery informatics market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America drug discovery informatics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America drug discovery informatics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list